`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`MYLAN PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`——————————
`
`Case IPR2021-00880
`U.S. Patent No. 9,669,069 B2
`
`PATENT OWNER’S MANDATORY NOTICES
`
`
`
`Case IPR2021-00880
`U.S. Patent No. 9,669,069 B2
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Regeneron Pharmaceuticals, Inc.
`
`(“Patent Owner”) respectfully submits the following mandatory notices in response
`
`to Petitioner Mylan Pharmaceuticals, Inc.’s (“Petitioner”) Petition for Inter Partes
`
`Review of U.S. Patent No. 9,669,069 B2 (“the ’069 patent”).
`
`I.
`
`37 C.F.R. § 42.8(b)(1): NOTICE OF REAL PARTY-IN-INTEREST
`
`The ’069 patent is currently assigned to Regeneron Pharmaceuticals, Inc.
`
`II.
`
`37 C.F.R. § 42.8(b)(2): RELATED MATTERS
`
`The ’069 patent is related to U.S. Patent No. 9,254,338 B2 (“the ’338
`
`patent”). Petitioner has separately filed an IPR petition on the ’338 patent
`
`(IPR2021-00881). In addition, Patent Owner further identifies Chengdu Kanghong
`
`Biotechnology Co. v. Regeneron Pharms., Inc., Case No. PGR2021-00035
`
`(P.T.A.B.) regarding U.S. Patent No. 10,828,345, which is also related to the ’069
`
`patent and the ’338 patent.
`
`III.
`
`37 C.F.R. § 42.8(b)(3): LEAD AND BACK-UP COUNSEL
`
`Patent Owner identifies the following lead and back-up counsel:
`
`Lead Counsel
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`Back-Up Counsel
`Amanda K. Antons (Reg. No. 65,236)
`Arnold & Porter Kaye Scholer LLP
`70 West Madison Street | Suite 4200
`Chicago, Illinois 60602-4321
`Telephone 312.583.2472
`Amanda.Antons@arnoldporter.com
`
`Alice S. Ho (Lim. Rec. No. L1162)
`
`-2-
`
`
`
`Case IPR2021-00880
`U.S. Patent No. 9,669,069 B2
`
`Victoria Reines (pro hac vice to be
`applied for)
`Rebecca Neubauer (pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Fax: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Rebecca.Neubauer@arnoldporter.com
`
`A concurrently filed power of attorney identifies the practitioners of Arnold
`
`& Porter Kaye Scholer LLP (Customer Number 180441), including Deborah E.
`
`Fishman, Amanda K. Antons, Alice S. Ho, Victoria Reines, and Rebecca Neubauer
`
`as attorneys of record.
`
`IV.
`
`37 C.F.R. § 42.8(b)(4): SERVICE INFORMATION
`
`Patent Owner may be served at the addresses found in Part III. Patent Owner
`
`consents to electronic service at:
`
`− Deborah.Fishman@arnoldporter.com
`
`− Amanda.Antons@arnoldporter.com
`
`− Alice.Ho@arnoldporter.com
`
`− Victoria.Reines@arnoldporter.com
`
`− Rebecca.Neubauer@arnoldporter.com
`
`− RegeneronEyleaIPRs@arnoldporter.com
`
`-3-
`
`
`
`Case IPR2021-00880
`U.S. Patent No. 9,669,069 B2
`
`Dated: May 24, 2021
`
`Respectfully submitted,
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deborah.Fishman@arnoldporter.com
`
`Amanda K. Antons (Reg. No. 65,236)
`Arnold & Porter Kaye Scholer LLP
`70 West Madison Street | Suite 4200
`Chicago, Illinois 60602-4321
`Telephone 312.583.2472
`Amanda.Antons@arnoldporter.com
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines (pro hac vice to be applied
`for)
`Rebecca Neubauer (pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Fax: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Rebecca.Neubauer@arnoldporter.com
`
`Attorneys for Patent Owner
`Regeneron Pharmaceuticals, Inc.
`
`-4-
`
`
`
`Case IPR2021-00880
`U.S. Patent No. 9,669,069 B2
`
`CERTIFICATE OF SERVICE
`The undersigned certifies that a copy of the foregoing PATENT OWNER’S
`
`MANDATORY NOTICES was served on May 24, 2021, to the following Counsel
`
`for Petitioner via e-mail at MYL_REG_IPR@rmmslegal.com:
`
`Paul J. Molino (Reg. No. 45,350)
`paul@rmmslegal.com
`William A. Rakoczy (pro hac vice to be filed)
`wrakoczy@rmmslegal.com
`Heinz J. Salmen (pro hac vice to be filed)
`hsalmen@rmmslegal.com
`Neil B. McLaughlin (Reg. No. 70,810)
`nmclaughlin@rmmslegal.com
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 222-6300
`Facsimile (312) 843-6260
`
`Attorneys for Petitioner Mylan Pharmaceuticals, Inc.
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`-i-
`
`